SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects
View SampleDownload Sample

Author: Giovanni Tosi

Series Title: Frontiers in Nanomedicine

Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects

Volume 2
eBook: US $39 Special Offer (PDF + Printed Copy): US $151
Printed Copy: US $131
Library License: US $156
ISSN: 2405-9129 (Print)
ISSN: 2405-9137 (Online)
ISBN: 978-1-68108-494-7 (Print)
ISBN: 978-1-68108-493-0 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810849301170201
Rate This Book

Introduction

Frontiers in Nanomedicine offers an up-to-date understanding of nanomaterials to readers having clinical or biomolecular research interests. Scientists, both aspiring and experienced, will find, in each volume, a comprehensive overview of current molecular strategies for using nanoscale materials in medicine.

Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects presents different aspects of nanomedicine applied to neuroscience for the diagnosis of disease and the role of nanoparticles in targeted drug delivery systems for neurodegenerative disorders. Topics covered in this volume cover the physiology of neurodegeneration, targeted therapies for Alzheimer’s disease and Parkinson’s disease, blood brain barrier drug delivery systems, in vivo studies of drug nanoconjugates, nanomedicine safety, and more.


eBook: US $39 Special Offer: US $151 Printed Copy: US $131 Library License: US $156

Contributors

Author(s):
Giovanni Tosi
Department of Life Sciences
University of Modena and Reggio Emilia
Modena
Italy



Contributor(s):
Tasnuva Sarowar
Neurology Dept., Neurocenter of Ulm University
WG Molecular Analysis of Synaptopathies
Ulm
Germany


Andreas M. Grabrucker
Neurology Dept., Neurocenter of Ulm University
WG Molecular Analysis of Synaptopathies
Ulm
Germany
/
Ulm University
Institute for Anatomy and Cell Biology
Ulm
Germany


Michal Cagalinec
Estonia Centre of Biosciences (former Institute of Molecular Physiology and Genetics), Slovak Academy of Sciences
Department of Pharmacology, Faculty of Medicine, University of Tartu, Tartu, Estonia Centre of Biosciences
Bratislava
Slovakia


Tonazzini Ilaria
Istituto Nanoscienze-CNR and Scuola Normale Superiore, Piazza San Silvestro 12
NEST
56127 Pisa
Italy


Cecchini Marco
Istituto Nanoscienze-CNR and Scuola Normale Superiore, Piazza San Silvestro 12
NEST
56127 Pisa
Italy
/
Piazza Velasca 5
Fondazione Umberto Veronesi
20122 Milano
Italy


Anne Mahringer
Institute of Pharmacy and Molecular Biotechnology, Im Neuenheimer Feld 329
Ruprecht-Karls University
69120 Heidelberg
Germany


Gert Fricker
Institute of Pharmacy and Molecular Biotechnology, Im Neuenheimer Feld 329
Ruprecht-Karls University
69120 Heidelberg
Germany


Cinzia M. Bellettato
Department of Women and Children Health, Via Giustiniani 3
Brains for Brains Foundation
35128 Padova
Italy


David J. Begley
Department of Women and Children Health, Via Giustiniani 3
Brains for Brains Foundation
35128 Padova
Italy
/
Institute of Pharmaceutical Science, Franklin-Wilkins Building, 150 Stamford Street
Kings College London
London, SE1 9NH
UK


Christina Lampe
Institute of Pharmaceutical Science, Franklin-Wilkins Building, 150 Stamford Street
Kings College London
London, SE1 9NH
UK
/
Department of Child and Adolescent Medicine
Center for Rare Diseases Helios Horst Schmidt Kliniken
Ludwig-Erhard-Straße 100 65199 Wiesbaden
Germany


Maurizio Scarpa
Institute of Pharmaceutical Science, Franklin-Wilkins Building, 150 Stamford Street
Kings College London
London, SE1 9NH
UK
/
Department of Child and Adolescent Medicine
Center for Rare Diseases Helios Horst Schmidt Kliniken
Ludwig-Erhard-Straße 100 65199 Wiesbaden
Germany
/
Department of Women and Children Health, Via Giustiniani 3
University of Padova
35128 Padova
Italy


Marika Salvalaio
Department of Women’s and Children’s Health, University of Padova
Laboratory of Diagnosis and Therapy of Lysosomal Disorders
Padova
Italy
/
Institute “Città della Speranza”
Pediatric Research
Padova
Italy


Laura Rigon
Department of Women’s and Children’s Health, University of Padova
Laboratory of Diagnosis and Therapy of Lysosomal Disorders
Padova
Italy


Francesca D’Avanzo
Department of Women’s and Children’s Health, University of Padova
Laboratory of Diagnosis and Therapy of Lysosomal Disorders
Padova
Italy
/
Foundation Onlus
Brains for Brain
Padova
Italy


Elisa Legnini
Department of Women’s and Children’s Health, University of Padova
Laboratory of Diagnosis and Therapy of Lysosomal Disorders
Padova
Italy


Valeria Balmaceda Valdez
Department of Women’s and Children’s Health, University of Padova
Laboratory of Diagnosis and Therapy of Lysosomal Disorders
Padova
Italy


Alessandra Zanetti
Department of Women’s and Children’s Health, University of Padova
Laboratory of Diagnosis and Therapy of Lysosomal Disorders
Padova
Italy


Rosella Tomanin
Department of Women’s and Children’s Health, University of Padova
Laboratory of Diagnosis and Therapy of Lysosomal Disorders
Padova
Italy


Ibane Abasolo
Vall d’Hebron Institut de Recerca (VHIR). Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
Functional Validation & Preclinical Research (FVPR). Drug Delivery & Targeting. CIBBIM-Nanomedicine
Barcelona
Spain


Yolanda Fernández
Vall d’Hebron Institut de Recerca (VHIR). Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
Functional Validation & Preclinical Research (FVPR). Drug Delivery & Targeting. CIBBIM-Nanomedicine
Barcelona
Spain


Simó Schwartz Jr.
Vall d’Hebron Institut de Recerca (VHIR). Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
Functional Validation & Preclinical Research (FVPR). Drug Delivery & Targeting. CIBBIM-Nanomedicine
Barcelona
Spain


Francesca Pederzoli
Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103
Te.Far.T.I
41124 Modena
Italy


Marianna Galliani
Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103
Te.Far.T.I
41124 Modena
Italy


Flavio Forni
Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103
Te.Far.T.I
41124 Modena
Italy


Maria Angela Vandelli
Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103
Te.Far.T.I
41124 Modena
Italy


Daniela Belletti
Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103
Te.Far.T.I
41124 Modena
Italy


Giovanni Tosi
Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103
Te.Far.T.I
41124 Modena
Italy


Barbara Ruozi
Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103
Te.Far.T.I
41124 Modena
Italy


Eva Rollerova
Faculty of Public Health, Department of Toxicology and Faculty of Medicine, Laboratory of Immunotoxicology
Slovak Medical University
Bratislava
Slovak Republic


Alzbeta Bujnakova Mlynarcikova
Institute of Experimental Endocrinology
Biomedical Research Center Slovak Academy of Sciences
Bratislava
Slovak Republic


Jana Tulinska
Faculty of Public Health, Department of Toxicology and Faculty of Medicine, Laboratory of Immunotoxicology
Slovak Medical University
Bratislava
Slovak Republic


Jevgenij Kovriznych
Faculty of Public Health, Department of Toxicology and Faculty of Medicine, Laboratory of Immunotoxicology
Slovak Medical University
Bratislava
Slovak Republic


Alexander Kiss
Institute of Experimental Endocrinology
Biomedical Research Center Slovak Academy of Sciences
Bratislava
Slovak Republic


Sona Scsukova
Institute of Experimental Endocrinology
Biomedical Research Center Slovak Academy of Sciences
Bratislava
Slovak Republic



RELATED BOOKS

.Role of Nanotechnology in Cancer Therapy.
.Nanomaterials for Environmental Applications and their Fascinating Attributes.
.Introduction to Carbon Nanomaterials.
.Frontiers in Nanomedicine.